Characteristics
|
Trajectory sample (n = 14,373)
|
Prospective sample (n = 12,129)
|
---|
Age, y
|
56.3 ± 8.1
|
63.3 ± 7.3
|
Sex
|
Women, n (%)
|
7839 (54.5)
|
6750 (55.7)
|
Men, n (%)
|
6534 (45.5)
|
5379 (44.4)
|
Race
|
White/Caucasian
|
9593 (66.7)
|
8140 (67.1)
|
African American/Black
|
3138 (22.0)
|
2605 (21.5)
|
Hispanic/Latino
|
1044 (7.3)
|
889 (7.3)
|
Asian/Chinese
|
571 (4.0)
|
495 (4.1)
|
Body mass index, kg/m2
|
27.6 (5.2)
|
28.4 (5.5)
|
Total cholesterol, mg/dL
|
206.7 (39.4)
|
197.3 (36.7)
|
LDL cholesterol, mg/dL
|
129.9 (36.8)
|
119.3 (33.1)
|
HDL cholesterol, mg/dL
|
52.2 (16.2)
|
51.7 (16.3)
|
Triglycerides, mg/dL
|
122.7 (63.6)
|
132.8 (77.4)
|
Systolic blood pressure, mmHg
|
120.9 (18.5)
|
125.1 (19.0)
|
Diastolic blood pressure, mmHg
|
72.5 (10.4)
|
70.6 (9.9)
|
Hypertension
|
4585 (32.0)
|
5271 (43.5)
|
Antihypertensive drug
|
3810 (26.5)
|
4586 (37.8)
|
Lipid-lowering drug use
|
2609 (18.2)
|
3799 (31.3)
|
Diabetes mellitus
|
1269 (8.8)
|
1730 (14.3)
|
Current smoking
|
2634 (18.4)
|
1569 (12.9)
|
Current drinking
|
8510 (59.5)
|
6114 (50.4)
|
- Numbers represent mean (standard deviation) for continuous and frequency (%) for categorical variables
- Characteristics for the trajectory sample were measured at the baseline (the first examination cycle)
- Characteristics for the prospective sample were measured at the fourth examination cycle
- HDL high-density lipoprotein, LDL low-density lipoprotein